Commercial breakthrough for Premaitha pre-natal test

Commercial breakthrough for Premaitha pre-natal test

Seneca EIS portfolio company Premaitha Health has won multiple contracts for its non-invasive prenatal test on pregnant women across Europe. The deal provides women on the continent privately and in the UK on the NHS with access to its ground breaking IONA test.

The AIM-listed company headquartered at Manchester Science Park has established a new enabling and clinical lab with plans to further increase capacity to meet significant and ongoing demand and substantial new international client enquiries.

Chairman of Premaitha David Evans said: “Premaitha has hit its key milestones as promised at the time of the reverse. We have delivered the world’s first CE-marked diagnostic product, signed contracts across Europe, including launching the first NHS test in the UK, and achieved recognition amongst our peers and key opinion leaders.”

See the article in full at

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.